Analysis
GoodMood Holdings, a Beijing-based AI-powered mental healthcare company, has raised nearly $45 million in a new financing round announced October 29, according to The SaaS News.
What GoodMood Holdings does
GoodMood Holdings combines digital clinical mental-health services with in-person specialty care, founded in 2016 and led by Chairman and CEO Chen Guanwei. The company says it now serves more than 14 million users and more than 600 enterprise clients. The new capital will go toward AI research and development, psychiatric and mental-health services, expansion of specialty clinics, and international growth, per The SaaS News' reporting. The company operates both an online platform for AI-assisted consultations and a network of physical specialty clinics, a hybrid model it says combines algorithmic triage with licensed clinicians for more complex cases.
GoodMood Holdings' funding history and disclosure gaps
The SaaS News' report does not state a round type, such as a Series C or a growth round, or a post-money valuation for the new $45 million raise, and it does not identify a lead investor among the five firms backing the round. That leaves real gaps in how to size this raise against any prior institutional funding GoodMood Holdings has disclosed, which the company's public reporting does not clearly lay out. Chinese growth-stage companies frequently omit valuation and round-type details from English-language funding announcements even when domestic regulatory filings contain them, so the gap here may reflect disclosure practice as much as any effort to obscure the number.
“GoodMood Holdings combines digital clinical mental-health services with in-person specialty care, founded in 2016 and led by Chairman and CEO Chen Guanwei.”
Who invested in GoodMood Holdings
Imeik Technology, CSC Financial Capital, Wuxi Binhu Industrial Group, Shandong Development and Unifuture Capital are all named as participants in the round, according to The SaaS News; none is identified as the lead investor.
The AI mental-health market in China
China's market for AI-powered mental-health chatbots and digital therapy tools was valued at $158 million in 2026, according to Towards Healthcare. The market is projected to reach $1.19 billion by 2035, a compound annual growth rate of 25.2%, part of a broader digital-health funding wave Value Add Pulse's own funding tracker has tracked across both US and Asian markets this year.
That growth trajectory helps explain why a company with an existing clinical user base is now emphasizing its AI capabilities to new investors, even without disclosing how much of its new round is earmarked specifically for AI development versus clinic expansion.
Scaling claims versus disclosed detail
GoodMood Holdings' user and client numbers are substantial, but the absence of a disclosed valuation, round type or lead investor makes this raise harder to benchmark than peers that publish full terms. Whether the company eventually discloses those figures, or faces investor questions about them as it pursues international expansion, is a bigger open question than the headline number suggests. For a company explicitly pitching international growth, investors outside China will likely want those terms before extending the same benefit of the doubt its domestic backers appear willing to give. The company has not disclosed how many of its 14 million users or 600 enterprise clients are based in China versus in the international markets it says the new capital will help it enter, a basic breakdown that would normally accompany a growth round of this size.